FDA requires GLP-1 drugs to warn about potential vision loss risk.
NAION is an eye stroke that can cause sudden, permanent vision loss and has no proven treatment.
FDA adds a rare vision-loss warning to popular GLP-1 drugs.
“STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition”
“Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss”
“FDA is requiring weight loss drug makers to add a vision loss warning”
“FDA tells GLP-1 makers to warn of potential vision loss side effect”
“GLP-1 drugs must have new warning label over incurable blindness condition, says FDA”
“FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s”
“FDA warns of rare vision-loss side effect from GLP-1 drugs”
AP News publishes the article.
concise.news reads it.
Grouped with 8 other reports as story 9.
The Brief ranks it 9th.
NAION is an eye stroke that can cause sudden, permanent vision loss and has no proven treatment.